Publication Cover
Canadian Journal of Pain
Revue canadienne de la douleur
Volume 6, 2022 - Issue 1
1,168
Views
0
CrossRef citations to date
0
Altmetric
Case Report

Successful conversion from butorphanol nasal spray to buprenorphine/naloxone using a low-dose regimen to assist with opioid tapering in the setting of chronic pain and migraine management in an older adult patient: A case report

, , & ORCID Icon
Pages 135-141 | Received 12 Jan 2022, Accepted 14 Jun 2022, Published online: 18 Aug 2022

Figures & data

Table 1. Initial assessment scores.

Table 2. Buprenorphine/naloxone regimen (Using micro-dosing for initiation).

Table 3. Summary of buprenorphine/naloxone tapering and corresponding clinical status.